FAOCX
Price
$31.05
Change
+$0.77 (+2.54%)
Updated
Apr 11 closing price
Net Assets
393.51M
RERAX
Price
$49.40
Change
+$0.83 (+1.71%)
Updated
Apr 11 closing price
Net Assets
116.48B
Ad is loading...

FAOCX vs RERAX

Header iconFAOCX vs RERAX Comparison
Open Charts FAOCX vs RERAXBanner chart's image
Fidelity Advisor Overseas C
Price$31.05
Change+$0.77 (+2.54%)
VolumeN/A
Net Assets393.51M
American Funds Europacific Growth R1
Price$49.40
Change+$0.83 (+1.71%)
VolumeN/A
Net Assets116.48B
FAOCX vs RERAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FAOCX vs. RERAX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAOCX is a Hold and RERAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 116B vs. FAOCX (394M). RERAX pays higher dividends than FAOCX: RERAX (0.46) vs FAOCX (0.38). FAOCX was incepted earlier than RERAX: FAOCX (27 years) vs RERAX (23 years). FAOCX (1.81) is less costly to investors than RERAX (1.57). FAOCX is a more actively managed with annual turnover of: 34.00 vs. RERAX (30.00). FAOCX has a lower initial minimum investment than RERAX: FAOCX (0) vs RERAX (250). FAOCX annual gain was more profitable for investors over the last year : 0.05 vs. RERAX (-9.46). FAOCX return over 5 years is better than : 48.49 vs. RERAX (17.34).
FAOCXRERAXFAOCX / RERAX
Total Expense Ratio1.811.57115%
Annual Report Gross Expense Ratio1.811.57115%
Fund Existence27 years23 years-
Gain YTD1.475-2.042-72%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets394M116B0%
Annual Yield % from dividends0.380.4683%
Returns for 1 year0.05-9.46-1%
Returns for 3 years12.58-3.27-385%
Returns for 5 years48.4917.34280%
Returns for 10 years38.791.612,416%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ETON12.450.48
+4.01%
Eton Pharmaceuticals
CLVT3.290.09
+2.81%
Clarivate Plc
EXEL35.310.85
+2.47%
Exelixis
HTBK8.260.01
+0.12%
Heritage Commerce Corp
ZVSA0.77N/A
-0.17%
ZyVersa Therapeutics